Target- |
MechanismInflammation mediators stimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date24 Dec 1997 |
100 Clinical Results associated with Sciarra Laboratories, Inc.
0 Patents (Medical) associated with Sciarra Laboratories, Inc.
27 Mar 2003·Drugs and the Pharmaceutical Sciences
Validation of Inhalation Aerosols
Author: Sciarra, John J. ; Sciarra, Christopher J.
A review describes the process of validation for new inhalation aerosol products.It discusses the principles for validating raw materials and manufacturing process of inhalation aerosols, and describes the validation protocol for these products.
100 Deals associated with Sciarra Laboratories, Inc.
100 Translational Medicine associated with Sciarra Laboratories, Inc.